This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Cerebrovascular Disease Related Topics 
Science Daily - Heart Disease
MAY 1, 2024
A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new study.
Medical Xpress - Cardiology
MAY 1, 2024
A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new UCLA Health study.
HCPLive
APRIL 26, 2024
A higher TRV was significantly associated with cerebrovascular disease and persistent albuminuria in children with SCD across two large cohorts.
Stroke Journal
FEBRUARY 1, 2024
Data was obtained through DataSUS, a public database.
Journal of the American Heart Association
DECEMBER 12, 2023
Journal of the American Heart Association, Ahead of Print.
Stroke Journal
JANUARY 18, 2024
Accumulating evidence supports a link between sleep disorders, disturbed sleep, and adverse brain health, ranging from stroke to subclinical cerebrovascular disease to cognitive outcomes, including the development of Alzheimer disease and Alzheimer disease–related dementias. Stroke, Ahead of Print.
90 
Circulation
DECEMBER 3, 2024
The use of some types of these products, for instance, is associated with an increased mortality risk in those with ischemic heart or cerebrovascular disease. Smokeless oral nicotine products are addictive, and their use has potential adverse effects on some but not all biomarkers of cardiovascular risk.
Cardiovascular Diabetology
AUGUST 27, 2024
Our subgroup analysis revealed that mothers with a history of GDM faced various risks (20% to 2-fold) of developing different subtypes of CVDs, including cerebrovascular disease, coronary artery disease, heart failure, and venous thromboembolism.
DAIC
JULY 29, 2024
Early identification allows for timely initiation of guideline-directed medical therapy for secondary prevention of cardiovascular disease, cerebrovascular disease, and limb events.
108 
Frontiers in Cardiovascular Medicine
NOVEMBER 25, 2024
Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism.
Medical Xpress - Cardiology
OCTOBER 16, 2024
New research published in the Journal of Stroke and Cerebrovascular Diseases confirms that strokes thought to happen in older adults are possible in the younger (defined as 18–50 years old) population.
52 
Stroke Journal
DECEMBER 11, 2024
Introduction of the antiamyloid immunotherapies into practice is therefore likely to present a new set of questions for clinicians treating patients with cerebrovascular disease: Which manifestations of cerebrovascular disease should preclude, or permit, antibody treatment?
Frontiers in Cardiovascular Medicine
JUNE 26, 2024
Hypertension is a significant risk factor for cardiovascular and cerebrovascular diseases and has become a global public health concern. Although hypertension results from a combination of factors, the specific mechanism is still unclear.
52 
Frontiers in Cardiovascular Medicine
MARCH 6, 2024
Results Brandenburg patients with cardiovascular diseases showed higher Lp(a) levels than healthy controls (24.2% vs. 14.8%, p = 0.001), and the high-Lp(a) group demonstrated a higher prevalence of coronary artery disease, peripheral artery disease, or cerebrovascular disease than the low-Lp(a) group ( p = 0.004).
59 
Frontiers in Cardiovascular Medicine
JANUARY 14, 2024
Methods This narrative review examines the contemporary literature assessing intermediate- and long-term event rates in patients with established CV disease treated with statins. Recurrent stroke occurs in up to 19% of patients seven years after a first cerebrovascular event.
Journal of Cardiovascular Pharmacology
APRIL 8, 2024
Multiple studies have shown that long non-coding RNAs (lncRNAs) play a significant role in the progression of cardiovascular and cerebrovascular diseases. Multiple studies have shown that long non-coding RNAs (lncRNAs) play a significant role in the progression of cardiovascular and cerebrovascular diseases.
40 
DAIC
FEBRUARY 9, 2024
The data were presented yesterday at the 2024 International Stroke Conference (AZ), a premier event featuring global thought leaders and dedicated to the latest in the science and treatment of cerebrovascular disease and brain health. A total of 17 sites and 123 patients participated across the United States and France.
105 
HeartRhythm
APRIL 30, 2024
However, the data on neurological outcomes including cerebrovascular disease (CVA) and dementia remain a controversy. Catheter ablation (CA) of atrial fibrillation (AF) has been proved to benefit patient with symptomatic AF and heart failure.
Journal of Cardiovascular Pharmacology
AUGUST 1, 2024
Thrombosis continues to pose a significant challenge in cardiovascular and cerebrovascular diseases, contributing to severe health complications such as myocardial infarction, acute ischemic stroke, and venous thromboembolism. In this paper, we comment the findings reported by Liu et al.
Frontiers in Cardiovascular Medicine
FEBRUARY 13, 2024
By comparing myocardial injury patients with non-myocardial injury patients, notable differences were observed in age, pre-existing medical conditions (e.g.,
64 Stroke Journal
FEBRUARY 1, 2024
ICD10 Codes I60-I69 were used to indicate cerebrovascular disease. CTA Head, CTP, MRI Brain, and Non-contrast CT Head imaging use was determined from Common Procedural Terminology (CPT) codes. Detailed diagnosis and hospital demographic data to be presented.
Stroke Journal
FEBRUARY 1, 2024
Introduction:Lipoprotein(a) [Lp(a)] is a known risk factor for cardiovascular disease; however, its association with cerebrovascular disease is not as well established.Methods:Data from HCHS/SOL, a population-based cohort of Hispanics/Latinos, was utilized.
Hypertension Journal
MARCH 28, 2024
BP, a heritable quantitative trait affected by numerous biological and environmental stimuli, is a major cause of morbidity and mortality worldwide and is considered to be a primary modifiable factor in renal, cardiovascular, and cerebrovascular diseases.
Hypertension Journal
JANUARY 2, 2024
Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide. Hypertension, Ahead of Print.
40 
Frontiers in Cardiovascular Medicine
JANUARY 21, 2024
Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL).
Open Heart
NOVEMBER 9, 2024
Patients with IONM were more likely to have had baseline cerebrovascular disease (60% vs 22%). Propensity-score matching was employed to assess the association of IONM usage with operative mortality and stroke. Results A total of 19 299 patients underwent a cardiac operation, of which 589 (3.1%) had IONM. vs 2.5%) and stroke (4.9%
DAIC
FEBRUARY 8, 2024
In the future, we hope to have more AI applications validated through clinical research and hope that the clinical decision support system can be expanded to include more aspects of stroke care, including reperfusion therapy and long-term secondary prevention, rehabilitation and so on.
105 
Stroke Journal
FEBRUARY 1, 2024
Introduction:Moyamoya is a progressive cerebrovascular disease characterized by stenosis of the cerebral arteries in the anterior circulation and less often the posterior circulation. Stroke, Volume 55, Issue Suppl_1 , Page AWP222-AWP222, February 1, 2024.
40 
Stroke Journal
FEBRUARY 1, 2024
Objectives:Moyamoya Disease (MMD) is a progressive occlusive cerebrovascular disease with unknown etiology and pathogenesis. Stroke, Volume 55, Issue Suppl_1 , Page ATP284-ATP284, February 1, 2024.
Stroke Journal
FEBRUARY 1, 2024
These variants included mutations in MYLK, COL5A1, COL5A2, KRIT1, CCM2, XPR1, MT-CYB, MT-ND4, and MT-ATP6 genes.This study highlights that in the right clinical population, like young patients with recurrent stroke, genetic testing can be helpful to elucidate the etiology of cerebrovascular disease when standard stroke work up is inconclusive.
40 
Stroke Journal
FEBRUARY 1, 2024
Introduction:Despite significant efforts to increase public awareness of cerebrovascular disease, the incidence of stroke and transient ischemic attack (TIA) in young adults has remained elevated, representing a major public health concern. Stroke, Volume 55, Issue Suppl_1 , Page ATP271-ATP271, February 1, 2024.
40 Stroke Journal
FEBRUARY 1, 2024
In patients with preexisting cerebrovascular disease, pollution exposure can compound underlying pathology and may accelerate functional decline. Stroke, Volume 55, Issue Suppl_1 , Page A18-A18, February 1, 2024. Background:Exposure to ambient air pollution causes neuroinflammation and white matter (WM) damage.
Journal of the American Heart Association
DECEMBER 1, 2023
BackgroundBrain arterial diameters (BADs) are novel imaging biomarkers of cerebrovascular disease, cognitive decline, and dementia. Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
IntroductionStroke is the most common manifestation of cerebrovascular disease, which requires prompt diagnosis and treatment. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023.
Stroke Journal
FEBRUARY 1, 2024
Introduction:Moyamoya disease (MMD) is a rare cerebrovascular disease that can lead to stroke. Stroke, Volume 55, Issue Suppl_1 , Page AWMP118-AWMP118, February 1, 2024.
Stroke Journal
FEBRUARY 1, 2024
This new modality using a physical parameter could lead to the development of innovative therapies to prevent and treat a wide array of cerebrovascular diseases. NIR-II photobiomodulation offers a non-invasive and low-risk treatment for stroke.
40 
All About Cardiovascular System and Disorders
MARCH 23, 2024
Relative contraindications for HUTT include: Severe left ventricular outflow obstruction Critical mitral stenosis Severe proximal coronary artery disease Severe cerebrovascular disease
Stroke Journal
OCTOBER 10, 2023
BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. Whether dialysis modality is associated with cerebrovascular disease is unclear. Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
IntroductionInterventional Neurology (IN) is a rapidly expanding field, with new devices and techniques broadening the range of cerebrovascular diseases that can be treated (1). Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
ConclusionLimb‐shaking TIA is an important yet underrecognized manifestation of relative cerebral hypoperfusion related to severe cerebrovascular disease. This case describes bilateral limb shaking episodes in a patient with severe bilateral carotid disease ‐ a rare manifestation of limb‐shaking TIA.
40 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
However, occult cerebral amyloid angiopathy can also present similarly, and their management is markedly different.MethodsWe present a case of recurrent bilateral medial frontal hemorrhage in a patient without known cerebrovascular disease that evaded diagnosis despite hematologic evaluation, MRI, CTA, two DSAs, three clot evacuations with pathology, (..)
40 Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
He had a documented history of transient‐ischemic attack and was noted to have undergone progressive cognitive decline.
40 
DAIC
JANUARY 23, 2024
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
Cardiomatics
AUGUST 4, 2022
According to WHO , cardiovascular diseases are the leading cause of death worldwide – it is estimated that they are the cause of 17.9 Cardiovascular diseases are a group of diseases of the heart and blood vessels. They include coronary artery disease, cerebrovascular disease, and rheumatic heart disease.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content